Appendix A: Search Details

April 22-2013 UPDATED July 15, 2014

Ovid MEDLINE(R) 1946 to April Week 2 2013

EBM Reviews - Cochrane Database of Systematic Reviews 2005 to March 2013

EBM Reviews - Cochrane Central Register of Controlled Trials March 2013

EBM Reviews - Database of Abstracts of Reviews of Effects 1st Quarter 2013

/ Searches / Results /
1 / exp "Estrogens, Conjugated (USP)"/ or exp Estradiol/ or exp Estrogen Replacement Therapy/ or "conjugated estrogen$".mp. or estradiol.mp. or "estrogen replacement therapy".mp. / 121247 / Estrogen
2 / misoprostol.mp. or exp Misoprostol/ / 5516
3 / Norethandrolone.mp. or exp Norethandrolone/ / 316
4 / tamoxifen.mp. or exp Tamoxifen/ / 25025
5 / estriol.mp. or exp Estriol/ / 7278
6 / (estrogen cream or Conjugated equine estrogen or premarin or estrace or estring or vagifem).mp. / 1436
7 / or/1-6 / 150768
8 / overactive bladder.mp. or exp Urinary Bladder, Overactive/ / 3830 / Vaginal disorders etc.
9 / exp Uterine Prolapse/ or "uterine prolapse".mp. / 4995
10 / exp Dyspareunia/ or dyspareunia.mp. / 3090
11 / exp Sexual Dysfunction, Physiological/ or sexual dysfunction.mp. / 26632
12 / exp Urinary Tract Infections/ or "urinary tract infection$".mp. / 50369
13 / exp Cystitis/ or cystitis.mp. / 10804
14 / exp Vaginal Diseases/ or "vaginal disease$".mp. / 20660
15 / exp Atrophic Vaginitis/ or "atrophic vaginitis".mp. / 165
16 / exp Vaginal Discharge/ / 1452
17 / exp atrophy/ and vagina$.mp. / 495
18 / exp Urinary Incontinence/ or (urin$ and incontinen$).mp. / 34116
19 / exp Dysuria/ or dysuria.mp. / 3117
20 / (vagina$ and (prolapse or irritat$ or dry$ or atrophy or bleed$ or discharge)).mp. / 17082
21 / or/8-20 / 153936
22 / 7 and 21 Estrogen and Vaginal disorders / 3816
23 / randomized controlled trial.pt. / 667570 / Compara-tive studies
24 / controlled clinical trial.pt. / 167714
25 / randomized controlled trials/ / 90268
26 / Random Allocation/ / 97361
27 / Double-blind Method/ / 216871
28 / Single-Blind Method/ / 28011
29 / clinical trial.pt. / 752849
30 / Clinical Trials.mp. or exp Clinical Trials/ / 322643
31 / (clinic$ adj25 trial$).tw. / 295939
32 / ((singl$ or doubl$ or trebl$ or tripl$) adj (mask$ or blind$)).tw. / 250152
33 / Placebos/ / 52305
34 / placebo$.tw. / 269609
35 / random$.tw. / 927234
36 / trial$.tw. / 738148
37 / (randomized control trial or clinical control trial).sd. / 242376
38 / (latin adj square).tw. / 4239
39 / Comparative Study.tw. or Comparative Study.pt. / 1775084
40 / exp Evaluation studies/ / 178631
41 / Follow-Up Studies/ / 501952
42 / Prospective Studies/ / 397398
43 / (control$ or prospectiv$ or volunteer$).tw. / 2940140
44 / Cross-Over Studies/ / 54742
45 / or/23-44 / 5726410
46 / 22 and 45 Comparative studies / 2528
47 / meta-analysis.pt. / 39653 / Systematic Reviews
48 / systematic$ review$.mp. [mp=ti, ab, ot, nm, hw, kf, ps, rs, ui, tx, kw, ct, sh] / 61576
49 / (systematic$ adj9 overview$).mp. / 1103
50 / (meta-analys$ or meta analys$ or metaanalys$).mp. [mp=ti, ab, ot, nm, hw, kf, ps, rs, ui, tx, kw, ct, sh] / 82204
51 / evidence review$.mp. [mp=ti, ab, ot, nm, hw, kf, ps, rs, ui, tx, kw, ct, sh] / 1423
52 / or/47-51 / 121755
53 / 22 and 52 Existing systematic reviews / 162
54 / 46 or 53 / 2535 / All
55 / limit 54 to english language [Limit not valid in CDSR,CCTR,DARE; records were retained] / 2385
56 / remove duplicates from 55
Ovid MEDLINE(R) <1946 to April Week 2 2013> (1536)
EBM Reviews - Cochrane Database of Systematic Reviews <2005 to March 2013> (95)
EBM Reviews - Cochrane Central Register of Controlled Trials <March 2013> (161)
EBM Reviews - Database of Abstracts of Reviews of Effects <1st Quarter 2013> (20) / 1812 / FINAL
57 / Update 7/15/2014 / +71 =
1883